About
Joined as Chief Technical Officer in October 2018 and added Chief Operating Officer in February 2020; promoted to President and COO in September 2022. Resigned as President and COO effective December 31, 2025 and transitioned to a part-time Chief Technical Advisor role. Former SVP of Quality and Regulatory CMC at AveXis.
Roles
4D Molecular Therapeutics, Inc.
Former President and Chief Operating Officer; Chief Technical Advisor · Current role
2018–present
Fixed Compensation
FY 2025Salary
$551,743
ComponentAnnual base salary
All other compensation
$1,612
Total compensation
$1,441,573
Performance Compensation
Data from FY 2025Cash incentive
Annual cash incentive
$339,513
FormNon-Equity Incentive Plan Compensation
Stock awards
Option awards
$548,705
FormStock options
Also at 4D Molecular Therapeutics, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.